KATELYN CLEOUS: Open Payments
NPI 1386230449 · POPLAR BLUFF, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$978 in 46 payments from 12 companies in 2025. Trend: 2023 $2,647 · 2024 $1,169 · 2025 $978
Food & beverage: $978
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $250 |
| Otsuka America Pharmaceutical, Inc. | 5 | $221 |
| Alkermes, Inc. | 12 | $189 |
| Braeburn Inc. | 4 | $75 |
| Janssen Pharmaceuticals, Inc | 3 | $58 |
| Exact Sciences Corporation | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| BioWound Solutions, Inc. | 1 | $31 |
| Vanda Pharmaceuticals Inc. | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
Products named: COBENFY, ABILIFY MAINTENA, ARISTADA, VIVITROL, REXULTI, BRIXADI, SPRAVATO, Cologuard Collection Kit.
Industry payments across MO — which companies pay providers there.
